November 7, 2016 / 9:52 PM / 9 months ago

BRIEF-Agile Therapeutics reports Q3 2016 financial results

Nov 8 (Reuters) - Agile Therapeutics Inc :

* Agile Therapeutics Inc - top-line data expected in early January 2017; resubmission planned for first half 2017

* Agile Therapeutics Inc - cash expected to fund operations through end of 2017

* Agile Therapeutics reports third quarter 2016 financial results and announces completion of subject visits for Twirla phase 3 secure clinical trial

* Q3 loss per share $0.27

* Q3 earnings per share view -$0.35 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below